Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (898K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (54)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Kuwabara, T.
Right arrow Articles by Taira, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuwabara, T.
Right arrow Articles by Taira, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 25, Issue 15 3074-3081, Copyright © 1997 by Oxford University Press


ARTICLES

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA

T Kuwabara, M Warashina, T Tanabe, K Tani, S Asano and K Taira
National Institute for Advanced Interdisciplinary Research, 1-1 Higashi, Tsukuba Science City 305, Japan.

With the eventual goal of developing a treatment for chronic myelogenous leukemia (CML), attempts have been made to design hammerhead ribozymes that can specifically cleave BCR-ABL fusion mRNA. In the case of L6 BCR-ABL fusion mRNA (b2a2 type; BCR exon 2 is fused to ABL exon 2), which has no effective cleavage sites for conventional hammerhead ribozymes near the BCR-ABL junction, it has proved very difficult to cleave the chimeric mRNA specifically. Several hammerhead ribozymes with relatively long junction-recognition sequences have poor substrate-specificity. Therefore, we explored the possibility of using newly selected DNA enzymes that can cleave RNA molecules with high activity to cleave L6 BCR-ABL fusion (b2a2) mRNA. In contrast to the results with the conventional ribozymes, the newly designed DNA enzymes, having higher flexibility for selection of cleavage sites, were able to cleave this chimeric RNA molecule specifically at sites close to the junction. Cleavage occurred only within the abnormal BCR- ABL mRNA, without any cleavage of the normal ABL or BCR mRNA. Thus, these chemically synthesized DNA enzymes seem to be potentially useful for application in vivo , especially for the treatment of CML, if we can develop exogenous delivery strategies.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. K. Uddin, Y. Kato, Y. Takagi, T. Mikuma, and K. Taira
Phosphorylation at 5' end of guanosine stretches inhibits dimerization of G-quadruplexes and formation of a G-quadruplex interferes with the enzymatic activities of DNA enzymes
Nucleic Acids Res., August 27, 2004; 32(15): 4618 - 4629.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. Shiota, M. Sano, M. Miyagishi, and K. Taira
Ribozymes: Applications to Functional Analysis and Gene Discovery
J. Biochem., August 1, 2004; 136(2): 133 - 147.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Bonaccio, A. Credali, and A. Peracchi
Kinetic and thermodynamic characterization of the RNA-cleaving 8-17 deoxyribozyme
Nucleic Acids Res., February 12, 2004; 32(3): 916 - 925.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Zhang, W. J. Gasper, S. A. Stass, O. B. Ioffe, M. A. Davis, and A. J. Mixson
Angiogenic Inhibition Mediated by a DNAzyme That Targets Vascular Endothelial Growth Factor Receptor 2
Cancer Res., October 1, 2002; 62(19): 5463 - 5469.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Khachigian, R. G. Fahmy, G. Zhang, Y. V. Bobryshev, and A. Kaniaros
c-Jun Regulates Vascular Smooth Muscle Cell Growth and Neointima Formation after Arterial Injury. INHIBITION BY A NOVEL DNA ENZYME TARGETING c-Jun
J. Biol. Chem., June 14, 2002; 277(25): 22985 - 22991.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kurreck, B. Bieber, R. Jahnel, and V. A. Erdmann
Comparative Study of DNA Enzymes and Ribozymes against the Same Full-length Messenger RNA of the Vanilloid Receptor Subtype I
J. Biol. Chem., February 22, 2002; 277(9): 7099 - 7107.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Q. Sun, M. J. Cairns, E. G. Saravolac, A. Baker, and W. L. Gerlach
Catalytic Nucleic Acids: From Lab to Applications
Pharmacol. Rev., September 1, 2000; 52(3): 325 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Peracchi
Preferential Activation of the 8-17 Deoxyribozyme by Ca2+ Ions. EVIDENCE FOR THE IDENTITY OF 8-17 WITH THE CATALYTIC DOMAIN OF THE MG5 DEOXYRIBOZYME
J. Biol. Chem., April 14, 2000; 275(16): 11693 - 11697.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. J. Cairns, A. King, and L.-Q. Sun
Nucleic acid mutation analysis using catalytic DNA
Nucleic Acids Res., February 1, 2000; 28(3): e9 - e9.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Li, W. Zheng, A. H. Kwon, and Y. Lu
In vitro selection and characterization of a highly efficient Zn(II)-dependent RNA-cleaving deoxyribozyme
Nucleic Acids Res., January 15, 2000; 28(2): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. C. Lowe, R. G. Fahmy, M. M. Kavurma, A. Baker, C. N. Chesterman, and L. M. Khachigian
Catalytic Oligodeoxynucleotides Define a Key Regulatory Role for Early Growth Response Factor-1 in the Porcine Model of Coronary In-Stent Restenosis
Circ. Res., October 12, 2001; 89(8): 670 - 677.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.